Response to Invited Commentary The Authors Respond to ‘‘HPV Persistence and Cervical Cancer Screening’’

Abstract

1 Cancer Prevention Fellowship Program, Division of Cancer Prevention, National Cancer Institute, Bethesda, MD. 2 Department of Epidemiology, School of Public Health, University of North Carolina, Chapel Hill, NC. 3 Department of Biostatistics, School of Public Health, University of North Carolina, Chapel Hill, NC. 4 Lineberger Comprehensive Cancer Center, School of Medicine, University of North Carolina, Chapel Hill, NC. 5 Worldwide Epidemiology, GlaxoSmithKline, Greenford, United Kingdom. 6 GlaxoSmithKline Biologicals, Rixensart, Belgium.

2 Figures and Tables

Cite this paper

@inproceedings{Koshiol2008ResponseTI, title={Response to Invited Commentary The Authors Respond to ‘‘HPV Persistence and Cervical Cancer Screening’’}, author={Jill Koshiol and Charles L Poole and Haitao Chu and Jeanne Marie Pimenta and Lisa Lindsay and David Jenkins and Jennifer Smith}, year={2008} }